Merck : MRK

All Merck Articles

1083 Articles

Jon C. Ogg | Jul 25, 2013 at 9:35 AM EDT

Short Sellers Make Big Changes in High-Yield Dividend Stocks

ThinkstockShort sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in…

Jon C. Ogg | Jul 11, 2013 at 11:15 AM EDT

Short Sellers Make Big Changes in High-Yield Dividend Stocks: AEP, Altria, Annaly and More

Short sellers are continuing to keep their bets against many of the top defensive high-yield dividend stocks. Increased volatility in…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Jon C. Ogg | Jun 26, 2013 at 11:25 AM EDT

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short sellers have really made some big changes in their bets against the key high-yield dividend stocks that had been…

Jon C. Ogg | Jun 12, 2013 at 9:30 AM EDT

Short Sellers Missed the Boat in Top High Dividend Stocks

Short sellers could have cleaned up by betting against the high dividend stocks in May and into June. Investors got…

Jon C. Ogg | Jun 8, 2013 at 7:45 AM EDT

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

This last week had much more volatility than what investors have grown used to. 24/7 Wall St. wanted to highlight…

Jon C. Ogg | Jun 6, 2013 at 8:00 AM EDT

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum…

Paul Ausick | Jun 3, 2013 at 4:04 PM EDT

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

U.S. equity markets opened higher this morning following a slightly upbeat report on eurozone manufacturing PMI. While not yet in…

Jon C. Ogg | May 31, 2013 at 2:22 PM EDT

Rising Interest Rate Risk For Big Dividends, Sector By Sector

The bull market appears to still be alive and well for equities, but the risk of rising interest rates is…

Jon C. Ogg | May 28, 2013 at 10:15 AM EDT

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

ThinkstockShort sellers are have previously been all over the place when it comes to the high-yield dividend stocks. The May 15…

Jon C. Ogg | May 28, 2013 at 8:00 AM EDT

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013.…

Douglas A. McIntyre | May 22, 2013 at 6:52 AM EDT

Media Digest: Reuters, WSJ, NYT, FT, Bloomberg

ThinkstockSony Corp. (NYSE: SNE) cuts forecasts for game console margins for the next several years. (MarketWatch) Sony also cuts targets…

Jon C. Ogg | May 14, 2013 at 7:50 AM EDT

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own…

Jon C. Ogg | May 10, 2013 at 12:01 PM EDT

Short Sellers Positions in Top Dividend Stocks

On the surface it looks like short sellers are all over the place in the latest short interest report. The…

Paul Ausick | May 1, 2013 at 4:08 PM EDT

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from…

1 … 52 53 54 55 56 … 73

Merck : MRK

All Merck Articles

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Short Sellers Make Big Changes in High-Yield Dividend Stocks: AEP, Altria, Annaly and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short Sellers Missed the Boat in Top High Dividend Stocks

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

Rising Interest Rate Risk For Big Dividends, Sector By Sector

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

Media Digest: Reuters, WSJ, NYT, FT, Bloomberg

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

Short Sellers Positions in Top Dividend Stocks

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

GLD’s 0.40% Fee Quietly Costs You $40 Per Year on Every $10,000 While Cheaper Rivals Charge Half

$200,000 at 65 Triggers $7,547 in Annual Withdrawals. Here’s What That Actually Covers

Dave Ramsey Says the ‘Actual Inappropriate One’ Is the Fiancé Who Wants Her to Stop Gifting Her Late Partner’s Family

$200,000 at 65 Triggers $7,547 in Annual Withdrawals. Here's What That Actually Covers

Dave Ramsey Says the 'Actual Inappropriate One' Is the Fiancé Who Wants Her to Stop Gifting Her Late Partner's Family

GLD’s 0.40% Fee Quietly Costs You $40 Per Year on Every $10,000 While Cheaper Rivals Charge Half

$200,000 at 65 Triggers $7,547 in Annual Withdrawals. Here’s What That Actually Covers

Merck : MRK

All Merck Articles

Short Sellers Make Big Changes in High-Yield Dividend Stocks

Short Sellers Make Big Changes in High-Yield Dividend Stocks: AEP, Altria, Annaly and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Short Sellers Are Tactical in Top High-Yield Dividend Stocks

Short Sellers Missed the Boat in Top High Dividend Stocks

Top Analyst Calls of the Week, Stocks to Buy, Stocks to Sell, Sector by Sector

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Closing Bell for Monday on Wall Street: Markets Wobble, But Finish Higher today

Rising Interest Rate Risk For Big Dividends, Sector By Sector

Short Sellers Become Tactical in the Top High-Yield Dividend Stocks

Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

Media Digest: Reuters, WSJ, NYT, FT, Bloomberg

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

Short Sellers Positions in Top Dividend Stocks

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

GLD’s 0.40% Fee Quietly Costs You $40 Per Year on Every $10,000 While Cheaper Rivals Charge Half

$200,000 at 65 Triggers $7,547 in Annual Withdrawals. Here’s What That Actually Covers

Dave Ramsey Says the ‘Actual Inappropriate One’ Is the Fiancé Who Wants Her to Stop Gifting Her Late Partner’s Family

Featured Reads

$200,000 at 65 Triggers $7,547 in Annual Withdrawals. Here's What That Actually Covers

Dave Ramsey Says the 'Actual Inappropriate One' Is the Fiancé Who Wants Her to Stop Gifting Her Late Partner's Family